Publicaciones en colaboración con investigadores/as de Pfizer (United States) (8)

2017

  1. Cardiovascular efficacy and safety of bococizumab in high-risk patients

    New England Journal of Medicine, Vol. 376, Núm. 16, pp. 1527-1539

2013

  1. Post hoc analysis of the cluster randomized usual care versus caduet Investigation Assessing Long-term Risk (CRUCIAL) trial

    Current Medical Research and Opinion, Vol. 29, Núm. 6, pp. 589-596

  2. Reduction in cardiovascular risk using proactive multifactorial intervention versus usual care in younger (<65 years) and older (≥65 years) patients in the CRUCIAL trial

    Current Medical Research and Opinion, Vol. 29, Núm. 5, pp. 453-463

2012

  1. Changes in calculated coronary heart disease risk using proactive multifactorial intervention versus continued usual care in Latin-American and non-Latin-American patients enrolled in the CRUCIAL trial

    Current Medical Research and Opinion, Vol. 28, Núm. 10, pp. 1667-1676

  2. Proactive cardiovascular risk management versus usual care in patients with and without diabetes mellitus: CRUCIAL trial Subanalysis

    Postgraduate Medicine, Vol. 124, Núm. 4, pp. 41-53

2011

  1. Proactive multiple cardiovascular risk factor management compared with usual care in patients with hypertension and additional risk factors: The CRUCIAL trial

    Current Medical Research and Opinion, Vol. 27, Núm. 4, pp. 821-833

2010

  1. Design and rationale of a real-life study to compare treatment strategies for cardiovascular risk factors: The CRUCIAL study

    Postgraduate Medicine, Vol. 122, Núm. 2, pp. 7-15

2008

  1. Amlodipine reduces predicted risk of coronary heart disease in high-risk patients with hypertension in Spain (The CORONARIA study)

    Journal of International Medical Research, Vol. 36, Núm. 6, pp. 1399-1417